QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online February 22, 2006
doi: 10.1242/10.1242/jcs.02783

This Article Figures Only Full Text Full Text (PDF) Supplementary Material Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nikitenko, L. L. Articles by Rees, M. C. P. Search for Related Content PubMed PubMed Citation Articles by Nikitenko, L. L. Articles by Rees, M. C. P. Social Bookmarking                         What's this?

Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms

¹ Nuffield Department of Obstetrics and Gynaecology, The University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK
² Molecular Angiogenesis Laboratory, Cancer Research UK, Weatherall Institute of Molecular Medicine, The University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK
³ Cancer Research UK Viral Oncology Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK
⁴ Nuffield Department of Clinical Laboratory Sciences, The University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK
⁵ AstraZeneca, CVGI, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK

^* Author for correspondence (e-mail: l.nikitenko{at}ucl.ac.uk)

Accepted 7 November 2005

Adrenomedullin (AM) and calcitonin gene-related peptide (CGRP) are related peptides with distinct pharmacological profiles. Calcitonin-receptor-like receptor (CRLR, now known as CL) can function as either an AM receptor or a CGRP receptor, when cotransfected with receptor-activity-modifying proteins (RAMPs) that define ligand-binding specificity. The aim of the present study was to determine the role of endogenously expressed CL (EndoCL) in generating endogenous AM and CGRP receptors. We raised anti-human CL antibody and identified microvascular endothelial cells (MVECs) as a major CL-expressing cell type in tissues by immunohistochemistry. Cultured MVECs continue to express EndoCL as well as fully active endogenous AM- and CGRP-sensitive receptors in vitro, as demonstrated by the ability of both peptides to induce migration and Akt phosphorylation. We therefore tested the hypothesis that endothelial EndoCL can interact with both AM and CGRP by examining receptor internalisation and desensitisation (loss of the ability to induce Akt phosphorylation). We found that agonist-mediated internalisation of EndoCL occurs in response to AM but not CGRP in MVECs. However, AM-induced EndoCL internalisation was blocked by antagonists of both AM and CGRP receptors: AM_22-52 and CGRP_8-37, respectively. Furthermore, AM-induced EndoCL internalisation resulted in desensitisation not only of AM but also of CGRP receptors. Finally, CGRP also induced desensitisation of both endogenous AM and CGRP receptors, but did not mediate EndoCL internalisation despite interaction with this receptor. Thus, EndoCL interacts with both AM and CGRP, and simultaneously acts as a receptor for both peptides (i.e acting as an endogenous AM/CGRP receptor) in endothelial cells. Interaction with either ligand is sufficient to induce EndoCL desensitisation to both AM and CGRP, but differential mechanisms are involved since only AM induces EndoCL internalisation. These novel findings regarding regulation of EndoCL function in endothelial cells are likely to be of importance in conditions where AM or CGRP levels are elevated, such as cardiovascular disease, diabetes and inflammation.

Key words: Adrenomedullin, CGRP, CRLR, Endogenous CL, Endothelial cell

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. Jin, K. Harada, S. Ohnishi, K. Yamahara, K. Kangawa, and N. Nagaya Adrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema Cardiovasc Res, December 1, 2008; 80(3): 339 - 345. [Abstract] [Full Text] [PDF]

				W. Ding, L. L. Stohl, J. A. Wagner, and R. D. Granstein Calcitonin Gene-Related Peptide Biases Langerhans Cells toward Th2-Type Immunity J. Immunol., November 1, 2008; 181(9): 6020 - 6026. [Abstract] [Full Text] [PDF]

				R. J. Vart, L. L. Nikitenko, D. Lagos, M. W.B. Trotter, M. Cannon, D. Bourboulia, F. Gratrix, Y. Takeuchi, and C. Boshoff Kaposi's Sarcoma-Associated Herpesvirus-Encoded Interleukin-6 and G-Protein-Coupled Receptor Regulate Angiopoietin-2 Expression in Lymphatic Endothelial Cells Cancer Res., May 1, 2007; 67(9): 4042 - 4051. [Abstract] [Full Text] [PDF]

				L. L. Nikitenko, T. Cross, L. Campo, H. Turley, R. Leek, S. Manek, R. Bicknell, and M. C.P. Rees Expression of Terminally Glycosylated Calcitonin Receptor-Like Receptor in Uterine Leiomyoma: Endothelial Phenotype and Association with Microvascular Density. Clin. Cancer Res., October 1, 2006; 12(19): 5648 - 5658. [Abstract] [Full Text] [PDF]